When we initiated our investigation of what renders CLL cells specifically vulnerable to AKT1 activation or SHIP1 inhibition, we found that additional activation of AKT1 increases oxidative phosphorylation, thereby triggering ROS-dependent cell death in CLL. The gene discussed is INPP5D; the disease is B-cell chronic lymphocytic leukemia.